首页> 外国专利> Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE4 inhibitor and antileukotriene for the treatment of inflammatory diseases

机译:抗胆碱能药,糖皮质激素,β2-激动剂,PDE4抑制剂和抗白三烯的组合治疗炎性疾病

摘要

#$%^&*AU2012200449A120120216.pdf#####COMBINATION OF ANTICHOLINERGICS, GLUCOCORTICOIDS, BETA2-AGONISTS, PDE4 INHIBITOR AND ANTILEUKOTRIENE FOR THE TREATMENT OF INFLAMMATORY DISEASES Abstract The invention relates to novel combinations based on anticholinergics, 02-adrenoceptor agonists, PDE 4 Inhibitors, glucocorticoids, and leukotriene-receptor antagonists, process for their production and their use for the treatment of inflammatory diseases, preferably respiratory diseases as bronchial asthma and chronic obstructive pulmonary diseases (COPD) or rheumatic or autoimmune diseases. (5866798_l):KZA
机译:#$%^&* AU2012200449A120120216.pdf #####抗菌药的组合糖皮质激素,BETA2-激动剂,PDE4抑制剂和抗原三烯的治疗。炎症性疾病抽象本发明涉及基于抗胆碱能药的新型组合,02-肾上腺素受体激动剂,PDE 4抑制剂,糖皮质激素和白三烯受体拮抗剂,其生产方法及其在治疗中的用途炎性疾病,最好是呼吸道疾病,如支气管哮喘和慢性阻塞性肺疾病(COPD)或风湿性或自身免疫性疾病。(5866798_l):KZA

著录项

  • 公开/公告号AU2012200449A1

    专利类型

  • 公开/公告日2012-02-16

    原文格式PDF

  • 申请/专利权人 MEDA PHARMA GMBH & CO KG;

    申请/专利号AU2012200449A1

  • 申请日2012-01-25

  • 分类号A61K45/06;A61K31/167;A61K31/40;A61K31/4015;A61K31/58;A61P1/04;A61P11/00;A61P11/06;A61P13/12;A61P17/06;A61P19/02;A61P25/28;A61P29/00;A61P37/00;A61P37/08;

  • 国家 AU

  • 入库时间 2022-08-21 17:19:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号